<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="30621">Arsenic trioxide</z:chebi> (<z:chebi fb="0" ids="30621">As2O3</z:chebi>) has been approved for the treatment of <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">APML</z:e>) and it is a promising candidate for the treatment of patients with <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo>, such as relapsed or refractory <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The effects of <z:chebi fb="0" ids="30621">As2O3</z:chebi> on B cells, specifically which do not express Bcl-2, have not been studied </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we have demonstrated that <z:chebi fb="0" ids="30621">As2O3</z:chebi>, at clinically achievable therapeutic concentrations, induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Bcl-2 negative human B cell line Ramos </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="30621">As2O3</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is associated with reduced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> transmembrane potential (delta psi), enhanced generation of intracellular reactive oxygen species (ROS), release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing factor (AIF) from mitochondria into cytoplasm, activation of caspases, and upregulation of Bax and <z:chebi fb="3" ids="33173">Bim</z:chebi> expression </plain></SENT>
<SENT sid="4" pm="."><plain>Exogenous <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) reverses the <z:chebi fb="0" ids="30621">As2O3</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a dose-dependent manner </plain></SENT>
<SENT sid="5" pm="."><plain>Altogether, these data indicate that <z:chebi fb="0" ids="30621">As2O3</z:chebi> induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in B cells, regardless of Bcl-2 expression, via the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathway by enhancing <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
</text></document>